About 123,000 results
Open links in new tab
Merck’s Clesrovimab (MK-1654), an Investigational Respiratory …
Merck's Clesrovimab Shows Effectiveness in RSV Prevention for …
With trial win, Merck looks to take on Sanofi, AZ in RSV
Merck Announces Topline Results from Phase 2b/3 Trial of …
Merck's RSV antibody for infants effective in reducing some types …
Merck says experimental RSV treatment protected infants in trial
New Data to be Presented at IDWeek 2024 Reinforce Merck’s …
Merck’s Clesrovimab (MK-1654), an Investigational ... - Nasdaq
MSD’s Clesrovimab (MK-1654), an Investigational Respiratory …
What can we help you find? - MSD